These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33895644)

  • 21. Clinical Characteristics and Risk Factors of Cardiac Involvement in COVID-19.
    Xu H; Hou K; Xu R; Li Z; Fu H; Wen L; Xie L; Liu H; Selvanayagam JB; Zhang N; Yang Z; Yang M; Guo Y
    J Am Heart Assoc; 2020 Sep; 9(18):e016807. PubMed ID: 32806998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19.
    Vasbinder A; Meloche C; Azam TU; Anderson E; Catalan T; Shadid H; Berlin H; Pan M; O'Hayer P; Padalia K; Blakely P; Khaleel I; Michaud E; Huang Y; Zhao L; Pop-Busui R; Gupta S; Eagle K; Leaf DE; Hayek SS;
    Circ Cardiovasc Qual Outcomes; 2022 Oct; 15(10):e008942. PubMed ID: 36193749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Markers of myocardial injury in the prediction of short-term COVID-19 prognosis.
    Calvo-Fernández A; Izquierdo A; Subirana I; Farré N; Vila J; Durán X; García-Guimaraes M; Valdivielso S; Cabero P; Soler C; García-Ribas C; Rodríguez C; Llagostera M; Mojón D; Vicente M; Solé-González E; Sánchez-Carpintero A; Tevar C; Marrugat J; Vaquerizo B
    Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):576-583. PubMed ID: 33153955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease.
    Barman HA; Atici A; Sahin I; Alici G; Aktas Tekin E; Baycan ÖF; Ozturk F; Oflar E; Tugrul S; Yavuz MB; Celik FB; Oktay A; Vahaboglu H; Adas M; Turgut N; Okuyan E; Yildirmak MT; Gungor B
    Coron Artery Dis; 2021 Aug; 32(5):359-366. PubMed ID: 32568741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis.
    Zhao YH; Zhao L; Yang XC; Wang P
    Rev Cardiovasc Med; 2021 Mar; 22(1):159-165. PubMed ID: 33792257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Myocardial Injury Assessed by High-Sensitive Cardiac Troponin Predicting Severe Outcomes and Death in Hospitalized Patients with COVID-19 Infection.
    Laouan Brem F; Chaymae M; Rasras H; Merbouh M; Bouazzaoui MA; Bkiyar H; Abda N; Zakaria B; Ismaili N; Housni B; El Ouafi N
    Clin Appl Thromb Hemost; 2022; 28():10760296221090227. PubMed ID: 35360970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association's COVID-19 Cardiovascular Disease Registry.
    Rodriguez F; Solomon N; de Lemos JA; Das SR; Morrow DA; Bradley SM; Elkind MSV; Williams JH; Holmes D; Matsouaka RA; Gupta D; Gluckman TJ; Abdalla M; Albert MA; Yancy CW; Wang TY
    Circulation; 2021 Jun; 143(24):2332-2342. PubMed ID: 33200953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
    Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
    Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical risk factors for mortality of hospitalized patients with COVID-19: systematic review and meta-analysis.
    Xiang G; Xie L; Chen Z; Hao S; Fu C; Wu Q; Liu X; Li S
    Ann Palliat Med; 2021 Mar; 10(3):2723-2735. PubMed ID: 33549005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of COVID-19 and Non-COVID-19 Hospitalized Pneumonia on Longer-Term Cardiovascular Mortality in People With Type 2 Diabetes: A Nationwide Prospective Cohort Study From Scotland.
    McGurnaghan SJ; McKeigue PM; Blackbourn LAK; Mellor J; Caparrotta TM; Sattar N; Kennon B; McAllister D; Wild SH; Colhoun HM;
    Diabetes Care; 2024 Aug; 47(8):1342-1349. PubMed ID: 38889071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?
    Zhang J; Lu S; Wang X; Jia X; Li J; Lei H; Liu Z; Liao F; Ji M; Lv X; Kang J; Tian S; Ma J; Wu D; Gong Y; Xu Y; Dong W
    Heart; 2020 Aug; 106(15):1148-1153. PubMed ID: 32451362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Cardio-Metabolic Disease Increases the Risk of Worse Outcomes Among Hospitalized Patients With COVID-19: A Multicenter, Retrospective, and Real-World Study.
    Chen Q; Wang L; Li C; Hu W; Fan Y; Chen Z; Wu L; Lu Z; Ye J; Chen S; Tong J; Ruan L; Mei J; Lu H
    J Am Heart Assoc; 2021 Jun; 10(12):e018451. PubMed ID: 34096317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association of cardiovascular disease with hospital mortality in COVID-19 patients].
    Pogosova NV; Ezhov MV; Barinova IV; Ausheva AK; Kuchiev DT; Popova AB; Arutyunov AA; Boytsov SA
    Kardiologiia; 2023 Nov; 63(10):63-71. PubMed ID: 37970857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review.
    Li X; Pan X; Li Y; An N; Xing Y; Yang F; Tian L; Sun J; Gao Y; Shang H; Xing Y
    Crit Care; 2020 Jul; 24(1):468. PubMed ID: 32723362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019.
    Liu Y; Cai J; Wang C; Jin J; Qu L
    J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1099-1111.e6. PubMed ID: 33529719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular diseases as risk factors of post-COVID syndrome: a systematic review.
    Sha'ari NI; Ismail A; Abdul Aziz AF; Suddin LS; Azzeri A; Sk Abd Razak R; Mad Tahir NS
    BMC Public Health; 2024 Jul; 24(1):1846. PubMed ID: 38987743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection.
    Lala A; Johnson KW; Januzzi JL; Russak AJ; Paranjpe I; Richter F; Zhao S; Somani S; Van Vleck T; Vaid A; Chaudhry F; De Freitas JK; Fayad ZA; Pinney SP; Levin M; Charney A; Bagiella E; Narula J; Glicksberg BS; Nadkarni G; Mancini DM; Fuster V;
    J Am Coll Cardiol; 2020 Aug; 76(5):533-546. PubMed ID: 32517963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-Analysis.
    Matsushita K; Ding N; Kou M; Hu X; Chen M; Gao Y; Honda Y; Zhao D; Dowdy D; Mok Y; Ishigami J; Appel LJ
    Glob Heart; 2020 Sep; 15(1):64. PubMed ID: 33150129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and impact of cardiac injury on COVID-19: A systematic review and meta-analysis.
    Fu L; Liu X; Su Y; Ma J; Hong K
    Clin Cardiol; 2021 Feb; 44(2):276-283. PubMed ID: 33382482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
    Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
    Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.